Navigation Links
Men with Enlarged Prostate and BPH Have Improved Options with Introduction of Urolift Procedure and 4KScore Prostate Cancer Test for Evaluation of Elevated PSA

NEW YORK, Sept. 3, 2014 /PRNewswire-USNewswire/ -- Symptoms of enlarged prostate affect millions of men, who suffer needlessly from frequent urination and difficulty emptying their bladder. Urinary tract obstruction from BPH can cause dangerous bladder problems in men including urinary retention, UTI and kidney failure.

According to Dr. Alex Shteynshlyuger, Director of Urology at New York Urology Specialists, "men with urinary problems should see an experienced urologist. Early treatment can prevent unpleasant complications." He adds that with modern treatment options such as the Urolift system for BPH and Greenlight laser, "the benefits are often dramatic and side effects are limited."

Urolift System for BPH and Enlarged Prostate is a same-day procedure that effectively treats men with BPH symptoms with few sexual side-effects of common BPH treatment options. For men who are not candidates for Urolift, other treatment options including Greenlight Laser are available.

For more information, visit:

It is important to know that men with symptoms of enlarged prostate may have prostate cancer that can cause similar urinary symptoms.

Traditionally, the PSA test has been recommended for early detection of prostate cancer. Many men with mildly elevated PSA and symptoms of enlarged prostate do not have prostate cancer.

Recently, for men with elevated PSA, improved tests that include 4KScore as well as Prostate Health Index (PHI) have become available. These tests can replace the PSA test as they provide improved information and can help avoid unnecessary biopsies. 4K score prostate cancer test helps predict which men are more likely to have aggressive prostate cancer. 

About New York Urology Specialists

New York Urology Specialists is an independent urology practice offering state-of-the-art urology care for complex urological conditions including frequent urination in men, enlarged prostate and BPH, and prostate cancer care.

About Dr. Alex Shteynshlyuger

Dr. Alex Shteynshlyuger is a board-certified urologist who specializes in caring for men and women with complex urological problems. He serves as the Director of Urology at New York Urology Specialists. His research has been recognized nationally.  

For more information, visit New York Urology Specialists on Facebook and Google+

MEDIA CONTACT:  Dr. Alex Shteynshlyuger, 1-646-663-4252,,

Logo -

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
ProfNet -

SOURCE New York Urology Specialists
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
4. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
7. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
8. Breakthrough Prostate Cancer Diagnostics
9. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
10. Prostate Cancer and Bone Health
11. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
Post Your Comments:
(Date:12/1/2015)... 1, 2015   MabVax Therapeutics Holdings, Inc . ... it has filed an Investigational New Drug Application (IND) ... the Company,s lead fully human antibody product HuMab 5B1 ... plans to initiate the Phase I clinical trial early ... --> The planned Phase I trial will evaluate ...
(Date:12/1/2015)... , Dec. 1, 2015   Craneware, Inc ... cycle solutions, today announced the company will showcase ... ChargeLink ® solution at the American ... Clinical Meeting . The new features are focused ... of monitoring and managing enterprise-wide pharmacy charges to ...
(Date:12/1/2015)... , Dec. 01, 2015 ... of the "Medical Alert Systems/Personal Emergency Response ... by Geography - Global Forecas" report to ... announced the addition of the "Medical Alert ... by End-User and by Geography - Global Forecas" ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... The Multiple System Atrophy Coalition has announced the launch of ... (MSA) research, timed today to coincide with Giving Tuesday 2015, a global day of ... to work and be productive, to do simple daily activities like walking to the ...
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, ... expansion of the company’s growing product line of food safety and seafood fraud ... Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
Breaking Medicine News(10 mins):